PATENT CLAIM ANALYSIS

Application Number: 15892343
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "061000"]

Abstract:
Muparfostat for use in reducing intrahepatic tumor recurrence and increasing disease-free survival period in a hepatocellular carcinoma patient with microvascular invasion after curative liver resection, while excluding HCC patients with no vascular invasion and HCC patients with macrovascular invasion, is disclosed. The hepatocellular carcinoma patient with microvascular invasion is identified by examining a resected liver tumor sample from the HCC patient for the presence of microvascular invasion in the sample.

Claim (Index 9):
The method of  claim 1 , wherein the HCC patient with microvascular invasion has a hepatic tumor with a size of smaller or no greater than 10 cm prior to the liver resection.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 88.0
- Lexical Diversity: 1.64444
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14439967', '11630170', '12999907', '12513219', '12095604']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7328635885714736
- 35 USC 102 Novelty (BERT): 0.5063154434270138
- Combined Prediction Score: 0.7102087740570276
- Mean Citation Score: 224.068758
- Max Citation Score: 236.64314
- Similarity Product: 165.75746393441202

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test